Skip to content
MedsAcross

Medicine

ONSWIK KwikPen 1000 IU/mL injection

Insulin efsitora alfa · Subcutaneous · Eli Lilly
Available on requestPrescription onlyUS FDA Cold chain

ONSWIK KwikPen 1000 IU/mL injection is a prescription medicine containing Insulin efsitora alfa for subcutaneous use, marketed by Eli Lilly, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Store ONSWIK refrigerated at 2°C to 8°C (36°F to 46°F) at all times. If…

Key facts

Active ingredient (INN)
Insulin efsitora alfa
Brand
ONSWIK KwikPen
Strength
1000 IU/mL
Dosage form
Injection
Route
Subcutaneous
Packs
1 syringe
Marketing authorisation holder
Eli Lilly
Manufacturer
Eli Lilly
Origin register
US FDA, United States
Storage
Store ONSWIK refrigerated at 2°C to 8°C (36°F to 46°F) at all times. If refrigeration is unavailable, the pen can be stored at room temperature up to 30°C (86°F) for up to a total of 14 days. Do not freeze ONSWIK. Dispose of ONSWIK that has been left at room temperature for longer than 14 days.
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.31Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
23 September 2026
Identifiers
RxCUI 2754149, 2754156, 2754159 +1DailyMed set ID 6e02229e-262c-4e25-9240-9e9de4eb7c1dNDC 0002-5240Application BLA761408

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 syringe in 1 carton / 3 mL in 1 syringe0002-5240-11Eli Lilly23 September 2026

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 23 September 2026Drugs@FDA
EU (EMA)OpinionEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Insulin efsitora alfa

Clinical summary

Insulin efsitora alfa is a prescription medicine indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is available as injection for subcutaneous use. MedsAcross supplies Insulin efsitora alfa for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Insulin efsitora alfa

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need ONSWIK KwikPen 1000 IU/mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.